It starts quietly. A few nights where sleep does not come easily, then does not feel restorative even when it does. An anxiety that does not attach itself to anything specific but does not leave either. You are tired in a way that rest does not fix. Your period arrives on schedule. Your doctor checks your thyroid. It is fine. You are told you are probably just stressed.
You are thirty-six years old. You have no idea that your hormones are already shifting.
A 2025 study published in npj Women’s Health analyzed data from more than 4,400 American women and found that over half of women between the ages of 30 and 35 reported perimenopausal symptoms classified as moderate or severe. That percentage rose to 64 percent for women aged 36 to 40. But the most significant finding was not the prevalence. It was what the symptoms looked like in younger women. Not hot flashes. Not night sweats. Anxiety. Depression. Brain fog. Irritability. Sleep disruption. The psychological symptoms arrive first, often years before the physical ones that most people associate with menopause.
Somewhere right now, a woman in her mid-thirties is sitting across from a therapist, being handed an antidepressant prescription, or quietly convinced she is falling apart, when what she is experiencing is the beginning of a hormonal transition nobody thought to name for her.
The average age of menopause in the United States is 51. Perimenopause, the transition that precedes it, can begin anywhere from seven to ten years earlier. That math puts the start of the perimenopausal window in a woman’s early forties for many, and in her mid-to-late thirties for others. The research has supported this for years. The clinical culture has not caught up.
Only 20 percent of ob-gyn residency programs include any training on menopause. The diagnostic framework most clinicians still use defines perimenopause primarily through menstrual cycle changes. But the emerging science is clear: the symptoms arrive before the cycle becomes irregular. A woman whose period is still on schedule can already be experiencing the brain and mood effects of declining estrogen. The hormone panel that might catch this is unreliable during perimenopause, because levels fluctuate dramatically month to month. There is no clean lab result. There is only a clinical picture, and most providers are not looking for it in a thirty-eight-year-old.
A January 2026 analysis from SFI Health found that nearly 40 percent of perimenopausal women with vasomotor symptoms remain untreated, often because their symptoms are attributed to stress, lifestyle, or normal aging by primary care providers. Women with regular menstrual cycles often assume they are too young for perimenopause. Providers rarely challenge that assumption. And so the symptoms accumulate, uncontextualized, attributed to everything except what is actually happening.
This matters beyond the discomfort of unmanaged symptoms. Estrogen affects sleep, cardiovascular function, bone density, and cognitive health in ways that compound over time. The perimenopausal window is increasingly understood as a critical period for long-term outcomes. The research connecting early estrogen decline to Alzheimer’s risk, to metabolic shifts like meno belly, to cardiovascular changes is building. What happens in this transition, and whether it is supported or ignored, may have consequences that reach decades past the last period.
Krista Russell-Adams was 37 when she entered perimenopause. She experienced anxiety, brain fog, persistently itchy ears, and changes to her skin. She told NPR that hormone therapy helped enormously, but getting there required time and self-advocacy. Her experience is not unusual. It is just more commonly labeled as something else: burnout, anxiety disorder, depression, the general overwhelm of being a woman in her late thirties holding too many things at once.
The study found that only 4.3 percent of women in the 30 to 35 age group had sought help for their symptoms, compared to more than half of women over 56. The gap is not explained by severity. The symptoms in younger women were rated moderate to severe at high rates. The gap exists because younger women do not know perimenopause is a possibility for them, and their doctors are not raising it.
Experts are now calling for a hybrid diagnostic model that incorporates symptom-based indicators rather than relying solely on cycle irregularity. That shift would mean asking women about anxiety, sleep, and brain function in their late thirties as part of a hormonal conversation, rather than routing them toward mental health diagnoses that treat the symptoms without addressing the source.
If you are in your mid-to-late thirties and something feels off in a way you cannot quite name, you are allowed to bring up perimenopause in the room. You are not too young to ask the question. And a doctor who tells you that you are is giving you incomplete information.
The information that could reframe years of unnecessary suffering exists. It is in the research. It just has not consistently made it to you yet.
